Repair after myocardial infarction, between fantasy and reality: the role of chemokines.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22115639.
- Also identified by DOI 10.1016/j.jacc.2011.08.034.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Despite considerable progress over the last decades, acute myocardial infarction continues to remain the major cause of morbidity and mortality worldwide. The present therapies include only cause-dependent interventions, which are not able to reduce myocardial necrosis and optimize cardiac repair following infarction. This review highlights the cellular and molecular processes after myocardial injury and focuses on chemokines, the main modulators of the inflammatory and reparatory events, as the most valuable drug targets.
Medical subject headings
- Cell- and Tissue-Based Therapy
- Chemokines
- Energy Metabolism
- Inflammation
- Myocardial Infarction
- Myocardium
- Myocytes, Cardiac